Tykveol capsule 450mg, No. 84

- type IIa and IIb hyperlipidemia;

- atherosclerosis (prevention);

- chronic hepatitis, hepatitis A (in combination therapy), toxic liver damage, liver cirrhosis, fatty liver disease, cholecystocholangitis, dyskinesia of the gallbladder and biliary tract;

- prostatic hyperplasia, chronic prostatitis;

- hemorrhoids.

Inside , 4 caps. during or after meals 3-4 times a day for 1-3 months. With prostatic hyperplasia - 1-2 caps. 3 times a day for 3-4 months; with chronic prostatitis - 1-2 caps. 3 times a day for 10 days to 3 months; with hyperlipidemia - 1-2 caps. 3 times a day for 3-4 months; for the prevention of atherosclerosis - 1-2 caps. per day for a long time; with diffuse liver damage, chronic cholecystitis, biliary dyskinesia - 3-4 caps. 3 times a day after meals, the duration of treatment is at least 3-4 weeks.

Soft gelatin capsules - 1 capsule

Complex of biologically active substances from pumpkin seeds (carotenoids, tocopherols, phospholipids, sterols, saturated, unsaturated and polyunsaturated fatty acids - palmitic, stearic, oleic, linoleic, linolenic)

capsule shell: medical gelatin, glycerol, sorbitol, purified water

- hypersensitivity to the drug;

- children under 12 years of age.

- peptic ulcer of the stomach and duodenum in the acute stage;

- cholelithiasis.

Composition:

Soft gelatin capsules - 1 capsule

Complex of biologically active substances from pumpkin seeds (carotenoids, tocopherols, phospholipids, sterols, saturated, unsaturated and polyunsaturated fatty acids - palmitic, stearic, oleic, linoleic, linolenic)

capsule shell: medical gelatin, glycerol, sorbitol, purified water

Capsules 450 mg, in polymer cans of 50 and 84 pcs .; in a pack of cardboard 1 can.

pharmachologic effect

Pharmacological action - antiproliferative, metabolic, antioxidant, antiatherosclerotic, regenerating, anti-inflammatory, choleretic, hepatoprotective .

Pharmacodynamics

It has a pronounced antioxidant effect, inhibiting the processes of lipid peroxidation in biological membranes.

The hepatoprotective effect is due to membrane stabilizing properties and manifests itself in slowing down the development of damage to the membranes of hepatocytes and accelerating their recovery. Normalizes metabolism, reduces inflammation processes, slows down the development of connective tissue and accelerates the regeneration of the parenchyma of the damaged liver. It has a choleretic effect, normalizes the impaired functional state of the gallbladder and the chemical composition of bile, reduces the risk of developing cholelithiasis.

Essential phospholipids are a structural element of cell membranes and hepatocyte membranes, regulate membrane permeability and oxidative phosphorylation processes, and contribute to the restoration of its structure and function.

It has a direct effect on the structure of epithelial tissues, providing differentiation and physiological function of the epithelium, reduces edema and improves microcirculation in trophic disorders and at the stage of epithelialization, has a protective effect on the granulation process, and stimulates metabolic processes in tissues. Inhibits proliferation of cells of the prostate gland with its benign hyperplasia, reduces the severity of inflammatory processes. Eliminates dysuric disorders in prostatic hypertrophy, pain syndrome in patients with prostatitis, has a bacteriostatic effect. With prolonged use, it reduces blood cholesterol levels (has a lipid-lowering effect).

Indications

- type IIa and IIb hyperlipidemia;

- atherosclerosis (prevention);

- chronic hepatitis, hepatitis A (in combination therapy), toxic liver damage, liver cirrhosis, fatty liver disease, cholecystocholangitis, dyskinesia of the gallbladder and biliary tract;

- prostatic hyperplasia, chronic prostatitis;

- hemorrhoids.

Contraindications

- hypersensitivity to the drug;

- children under 12 years of age.

- peptic ulcer of the stomach and duodenum in the acute stage;

- cholelithiasis.

Side effects

Increased stool is possible (dose reduction required).

Method of administration and dosage:

Inside , 4 caps. during or after meals 3-4 times a day for 1-3 months. With prostatic hyperplasia - 1-2 caps. 3 times a day for 3-4 months; with chronic prostatitis - 1-2 caps. 3 times a day for 10 days to 3 months; with hyperlipidemia - 1-2 caps. 3 times a day for 3-4 months; for the prevention of atherosclerosis - 1-2 caps. per day for a long time; with diffuse liver damage, chronic cholecystitis, biliary dyskinesia - 3-4 caps. 3 times a day after meals, the duration of treatment is at least 3-4 weeks.

Precautions

Overdose should not be allowed.

Storage conditions

In a dark place at a temperature of 15-25 ? C.

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiration date printed on the package.